Delivery Order 75N94024D00003-75N98026F00003
Award Date 7/8/26
Potential Completion Date 9/30/26
Potential Value $411K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Tonawanda, NY 14150, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institutes of Health issued a $39,278.50 delivery order to Pine Pharmaceuticals LLC on April 21, 2026, under a total small business set-aside for oral stable isotope-deuterium oxide, with final delivery by June 1, 2026. Pine Pharmaceuticals is a small business pharmaceutical compounding and manufacturing firm. Place of performance is Tonawanda, NY. The order ceiling is $39,278.50 under firm fixed-price terms, with ultimate completion scheduled for October 30, 2026. Billing is in one...
- This is a $121,989 firm fixed-price purchase order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The contract is to provide specialized pharmaceutical products and services, including the manufacture of stable isotopes, placebo capsules, and other compounds used in medical...
- Veterans Integrated Service Network 23 issued a $21,672.80 delivery order to Pine Pharmaceuticals LLC on October 1, 2025, for 503B compounding pharmaceuticals with a ceiling value of $21,672.80 and ultimate completion date of March 31, 2026. Place of performance is Tonawanda, NY. Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility specializing in pharmaceutical compounding and repackaging for federal agencies, with over 37 years of operational history. This delivery order is...
- The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $24,850 firm fixed price purchase order to Cambridge Isotope Laboratories, Inc., doing business as Cambridge Isotope Labs, located in Tewksbury, Massachusetts. The contract is for the acquisition of 35 five-gram bottles of deuterium-labeled D-glucose (1,2,3,4,5,6,6D7, 9798%) to support the NIH-NIDDK's research programs. The period of performance is from August 23, 2023 through September...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Government Scientific Source Inc. for the procurement of D-GLUCOSE-13C6, 99 ATOM % 13C, a non-hazardous chemical product. The contract has a ceiling value of $24,477.50 and a period of performance ending on September 30, 2023. The contract does not have a set-aside designation. Government Scientific Source Inc. is a leading distributor of laboratory...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $21,486.10 firm fixed-price purchase order contract to Life Chemicals USA, Inc., a self-certified small disadvantaged business, for an "ION CHANNEL SCREENING LIBRARY" with a completion date of July 31, 2023. The contract does not have a set-aside designation. Based on the agency name, this award is likely associated with NIDDK's research activities related to diabetes, digestive, and kidney...
- This is a $40,500 firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Polyorg, Inc., a for-profit manufacturer located in Leominster, MA. The order is for specialized chemical reagents including Fmoc-PNA monomers and Bhoc Nucleobase Acids, which are essential starting materials for NIDDK's research on thyclotides - molecules with potential diagnostic applications. The purchase order was awarded on a sole-source basis under...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded a firm-fixed-price purchase order to Cyclope Bio SL for $80,000 on August 1, 2026. Performance occurs in Spain with an ultimate completion date of July 31, 2027. The order procures 200 grams of (1S,2S)-trans-N-Boc-1,2-cyclopentanediamine, a chemical precursor for synthesizing cyclopentane peptide nucleic acids and thyclotides in support of preclinical HIV detection, prevention, and treatment research funded by the NIH...
- <p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation on September 15, 2016, for various laboratory supplies with a firm fixed price of $6,684.06. Performance will occur in Grand Island, New York. The order carries an ultimate completion date of September 19, 2017.</p>
- This federal contract award, valued at $51,248.00, was issued by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Polyorg, Inc., a manufacturer of specialty chemicals. The award was a firm fixed-price purchase order for the delivery of 80 grams of A(Bhoc)-OH, 120 grams of C(Bhoc)-OH, and 160 grams of G(Bhoc)-OH, which are key building blocks for the development of thyclotides and cyclopentane peptide nucleic acids. These materials...